Kristin Peck
CEO Peck's ability to execute, demonstrated when she resolved major manufacturing issues, and her key role in the 2013 spin-off, position her to drive earnings in new markets.
Sources say Peck is collaborative and decisive, but her confidence makes it difficult for others to change her mind, creating a risk she may hire people unwilling to challenge her.
Peck's strategic vision will be crucial as she navigates a disappointing drug launch by driving innovations in new areas for Zoetis, such as oncology and cardiology.
By submitting this form, you are agreeing to ManagementTrack’s Privacy Policy. You can choose to opt out of marketing or advertising emails using the ‘unsubscibe’ link included in our emails.
The best
The best
The best
Our investigative journalists interview the top former colleagues of the CEOs you care about.
Our former buysider analysts summarize the key strengths & weaknesses, past successes & failures, and ability to drive value going forward.
You get access to the actual anonymized transcripts and insights.